Subtype
Glioneuronal and Neuronal Tumors
CI-CAN-00000936Explore in graph →
Non-malignant5 active trials6 evidence items
- NCIt
- C4747
Loading cancer entity…
Subtype
CI-CAN-00000936Explore in graph →
Clinical trials
15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04065776 | Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma | active not recruiting | N/A | 48 | St. Jude Children's Research HospitalOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | active not recruiting | Phase 4 | 163 | Novartis PharmaceuticalsINDUSTRY | 19 | Aug 27, 2026 | clinicaltrials |
| NCT03919071 | Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma | active not recruiting | Phase 2 | 58 | National Cancer Institute (NCI)NIH | 2 | Jul 10, 2026 | clinicaltrials |
| NCT03152318 | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials
| active not recruiting |
| Phase 1 |
| 62 |
| Dana-Farber Cancer InstituteOTHER |
| 1 |
| Mar 4, 2026 |
| clinicaltrials |